Gertrude Cene Augustin
Gertrude Cene Augustin has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Damien Slater
Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA
2 shared publications Jason B. Harris
2 shared publications- Louise C. Ivers
Center for Global Health, Massachusetts General Hospital, Boston, Massachusetts
2 shared publications Ralph Ternier
Partners In Health/Zanmi Lasante, Croix des Bouquets, Haiti
2 shared publicationsYodeline Guillaume
Center for Global Health, Massachusetts General Hospital, Boston, MA, USA
2 shared publications- Alain Casseus
Zanmi Lasante, Croix-des-Bouquets, Haiti
1 shared publication
Latest Publications
- Open Access
- 20 January 2026
- Published by Elsevier in SSRN Electronic Journal
5-Year Effectiveness of An Oral Cholera Vaccine in a Cholera Outbreak in Rural Haiti: A Case-Control Study
Background: The World Health Organization recommends use of killed oral cholera vaccines (kOCV) as part of cholera prevention and control, but data on the duration of effectiveness of the most widely available vaccine, Euvichol® is limited. We evaluated the effectiveness of Euvichol® 5 years after a kOCV campaign conducted in Haiti in 2017.Methods: We undertook a frequency-matched case-control study in Mirebalais, Haiti from October 2022 to February 2023 as a cholera outbreak resurged. Cases were patients with acute watery diarrhea, had a stool sample positive for V. cholerae by polymerase chain reaction, and had been eligible for kOCV during the 2017 campaign. Cases were frequency-matched with community controls by age group and neighborhood. Participants reported sociodemographics, risk factors, and vaccination status. We used adjusted logistic regression analyses to estimate vaccine effectiveness (VE) of at least one kOCV dose versus none.Findings: We analyzed 93 cases and 135 controls. 22% of the cases and 51% of the controls self-reported vaccination. Receiving Euvichol in 2017 was associated with a 5-year adjusted VE of 78% (95% CI: 57%-89%, p<0.0001).Interpretation: Euvichol® effectively protected against cholera in Haiti, 5 years after a vaccination campaign. This has important implications for public health planning, especially consideration of re-dosing schedules and comparative effectiveness analyses.
- 20 January 2026
- Published by Elsevier in SSRN Electronic Journal
Open Access5-Year Effectiveness of An Oral Cholera Vaccine in a Cholera Outbreak in Rural Haiti: A Case-Control Study
Background: The World Health Organization recommends use of killed oral cholera vaccines (kOCV) as part of cholera prevention and control, but data on the duration of effectiveness of the most widely available vaccine, Euvichol® is limited. We evaluated the effectiveness of Euvichol® 5 years after a kOCV campaign conducted in Haiti in 2017.Methods: We undertook a frequency-matched case-control study in Mirebalais, Haiti from October 2022 to February 2023 as a cholera outbreak resurged. Cases were patients with acute watery diarrhea, had a stool sample positive for V. cholerae by polymerase chain reaction, and had been eligible for kOCV during the 2017 campaign. Cases were frequency-matched with community controls by age group and neighborhood. Participants reported sociodemographics, risk factors, and vaccination status. We used adjusted logistic regression analyses to estimate vaccine effectiveness (VE) of at least one kOCV dose versus none.Findings: We analyzed 93 cases and 135 controls. 22% of the cases and 51% of the controls self-reported vaccination. Receiving Euvichol in 2017 was associated with a 5-year adjusted VE of 78% (95% CI: 57%-89%, p<0.0001).Interpretation: Euvichol® effectively protected against cholera in Haiti, 5 years after a vaccination campaign. This has important implications for public health planning, especially consideration of re-dosing schedules and comparative effectiveness analyses.
- Open Access
- 6 July 2024
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 147, 107165
Association between chlorine-treated drinking water, the gut microbiome, and enteric pathogen burden in young children in Haiti: An observational study
- 6 July 2024
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 147, 107165
Open AccessAssociation between chlorine-treated drinking water, the gut microbiome, and enteric pathogen burden in young children in Haiti: An observational study
- Open Access
- 22 November 2023
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 139, 153-158
Effectiveness of the Euvichol® oral cholera vaccine at 2 years: A case-control and bias-indicator study in Haiti
- 22 November 2023
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 139, 153-158
Open AccessEffectiveness of the Euvichol® oral cholera vaccine at 2 years: A case-control and bias-indicator study in Haiti